Bacterial Disease Diagnostics Market Size & Share, by Type (Bacterial Skin Infections, Sexually Transmitted Infections, Foodborne Infections); Product (Consumables, Instruments); Technology (Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction, DNA Microarray, Immunodiagnostics); End-user (Hospitals, Labs, Research Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Bacterial Disease Diagnostics Market size is estimated to surpass USD 8 Billion by the end of 2035, witnessing around 8% CAGR during the forecast period i.e., 2023 – 2035. In the year 2022, the industry size of bacterial disease diagnostics was USD 3 Billion. The growth of the market can be attributed to the growing incidences of mass food poisoning. In the world, around 600 million fell ill due to the consumption of contaminated food and nearly 33 million lost their lives. Bacterial illness is a leading cause of food poisoning in humans. As consumers become increasingly worried about food safety, the demand for trustworthy bacterial illness diagnostics grows.

In addition to this, one aspect that is expected to drive the growth of the bacterial disease diagnostics market is rising research on new treatments and diagnoses. BARDA has collaborated with the government to help a number of companies research novel infectious disease medications. Ongoing research aids in the identification and description of new bacterial pathogens. Researchers can aid in the development of diagnostic tests for these novel infections, aiding disease control.


Bacterial Disease Diagnostics Market
Get more information on this report: Request Free Sample PDF

Bacterial Disease Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Government Initiatives for Better Healthcare– In 2021, the World Health Organization started the initiative Global Health and Peaces to address the critical health needs of people and to address 70% of disease outbreaks under this program. Bacterial illness diagnostics are critical for early diagnosis and prompt management of infections, which coincides with the government's preventative healthcare aims.
  • Increasing Emissions from Vehicles– Motor vehicles emit around 1.5 billion tonnes of greenhouse gases (GHGs) directly into the atmosphere each year. Poor air quality is linked to respiratory problems as well as compromised immune systems, rendering people more susceptible to bacterial illnesses. Therefore, the growing vehicular emissions will increase the need for bacterial disease diagnostics to treat infections.
  • Growing Need for Wastewater Treatment- Around 50% of wastewater generated in the world is carefully treated. To test the effectiveness of water and wastewater treatment, the need for bacterial diagnosis becomes highly important. Screening indicator bacteria levels in wastewater aids in making sure that the outcome of residential and industrial wastewater treatment is safe for discharge into the environment.

Challenges

  • Lack of Skilled Personnel and Adequate Infrastructure- Many developing countries do not have well-established infrastructure for advanced diagnostic technologies. Moreover, there is a lack of funds and skilled people to carry on the procedure effectively.
  • Low Awareness Regarding the Diagnosis of Bacterial Diseases
  • High Cost of Manufacturing

Bacterial Disease Diagnostics Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~8%

Base Year Market Size (2022)

~ USD 3 Billion

Forecast Year Market Size (2035)

~ USD 8 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Bacterial Disease Diagnostics Segmentation

Type (Bacterial Skin Infections, Sexually Transmitted Infections, Foodborne Infections)

The bacterial skin infections segment in the bacterial disease diagnostics market is estimated to gain the largest revenue share of about 45% in the year 2035. The growth of the segment can be attributed to the rising skin problem among the people. Skin is the most exposed part of the body, therefore many people get affected by acne, infection, and allergies caused by bacterial growth. Acne is the 8th most common disease in the world and affects around 9% of the total global population.

End User (Hospitals, Labs, Research Centers)

Bacterial disease diagnostics market from hospital segment is expected to garner a significant share of around 40% in the year 2035. Hospitals play a significant part in patient care, and good diagnostic procedures are key for guiding treatment plans, improving patient outcomes, and limiting infection spread. Furthermore, the governments of various countries are increasing the budget for setting up hospital infrastructures, which is expected to drive the growth of the segment.

Our in-depth analysis of the global market includes the following segments:

          Type

  • Bacterial Skin Infections
  • Sexually Transmitted Infections
  • Foodborne Infections

          Product

  • Consumables
  • Instruments

          Technology

  • Isothermal Nucleic Acid Amplification Technology
  • Polymerase Chain Reaction
  • DNA Microarray
  • Immunodiagnostics

          End User

  • Hospitals
  • Labs
  • Research Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Bacterial Disease Diagnostics Industry- Regional Synopsis

North American Market Forecast

The market share of bacterial disease diagnostics in North America, is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed majorly to the rising instances of fatal infections caused by bacteria in the region. The growing changes in the climatic conditions have led to its warming and have significantly increased the chances of bacterial infections. According to the latest research performed by the University of East Anglia (UEA) in the United Kingdom, the United States has become the hotspot of bacterial illness. The frequency of V. vulnificus infections in the United States has increased from 10 to 80 annually over 30 years.

APAC Market Statistics

The Asia Pacific bacterial disease diagnostics market is estimated to be the second largest, registering a share of about 28% by the end of 2035. The growth of the market can be attributed majorly to the rising cases of typhoid in the region. In the rainy season, the climate in India becomes extremely humid, owing to which, every year typhoid cases witness a jump of 30% in the monsoon. The cases are higher in rural regions but in 2023, the cases significantly increased in urban areas as well.

Research Nester
Bacterial Disease Diagnostics Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Bacterial Disease Diagnostics Landscape

top-features-companies
    • bioMérieux SA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffmann-La Roche Ltd
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • DiaSorin SpA (Luminex)
    • Accelerate Diagnostics Inc.
    • Bruker Corp.
    • Danaher Corp.
    • Torus Biosystems
    • GENERI BIOTECH s.r.o.

In-the-news

In The News

  • F. Hoffmann-La Roche Ltd. announced the collaboration with Janssen Biotech Inc. to expand its diagnosis portfolio for target therapies. It increases innovation and strengthens diagnostic technology.
     
  • bioMerieux launched the new CE-marking of VIDAS® KUBE™, it is a automated immunoassay system for VIDAS range. This will aid both clinical laboratories and the food industry to serve their customers rapidly.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5206
  • Published Date: Sep 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of bacterial infection and technological advancement in diagnostic technology are the major factors driving the market growth.

The market size of bacterial disease diagnostics is anticipated to attain a CAGR of ~8% over the forecast period, i.e., 2023 – 2035.

The major players in the market are bioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company, DiaSorin SpA (Luminex), Accelerate Diagnostics Inc., Bruker Corp., Danaher Corp., Torus Biosystems, and GENERI BIOTECH s.r.o.

The bacterial skin infection segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Bacterial Disease Diagnostics Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying